Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cannabinoid modulation of neuroinflammatory disorders.
[Adaptative immunity and pathophysiology of multiple sclerosis.]
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy.
Clutter management for individuals with multiple sclerosis.
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
Altered thalamic functional connectivity in multiple sclerosis.
Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.
Platelets and vascular inflammation of the brain.
Asynchrony in Executive Networks Predicts Cognitive Slowing in Multiple Sclerosis.
Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation.
B cells in Multiple Sclerosis: Good or bad guys?: An article for 28 May 2014 - World MS Day 2014.
Acupuncture and multiple sclerosis: a review of the evidence.
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Mutation Update of ARSA and PSAP genes causing Metachromatic Leukodystrophy.
Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration.
Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: a vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?
Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Editorial: Plasticity in Multiple Sclerosis: From Molecular to System Level, from Adaptation to Maladaptation.
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.
Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective.
Effects of Single Bouts of Walking Exercise and Yoga on Acute Mood Symptoms in People with Multiple Sclerosis.
Pages
« first
‹ previous
…
520
521
522
523
524
525
526
527
528
…
next ›
last »